|Grant Affiliation:||Weiss: Protection by Neutralizing Antibodies|
|Strategy:||Protein & peptide vaccines|
|Study Type:||Pre-Clinical Non-NHP|
|Study Start Date:||2007-05-22|
|Study Made Public:||2011-06-21|
Comparative analysis of CN54 gp140 immunogenicity in 3 different adjuvants
CAVD 285 is a continuation of CAVD 284, assessing the neutralization activity induced by the clade C trimeric gp140 antigen derived from clade C HIV-1 CN54, combined with different adjuvants.
Sign in to see full information about this study and to download study data.